Abstract Introduction: Cannabis is one of the most commonly used psychoactive substances globally. Cannabidiol (CBD) is a non‐intoxicating cannabis compound…
Abstract Background: People with Parkinson’s disease (PD) may use cannabis-based products for symptom management. In France, products containing tetrahydrocannabinol (THC)…
Abstract Cannabinoids may help people with PD to manage their symptoms. Acceptability of cannabis and cannabidiol was high in French…
Abstract Background: People with HIV (PWH) with undetectable HIV viral load still have an impaired health-related quality of life (HRQoL).…
Abstract Obesity and nonalcoholic fatty liver disease (NAFLD) constitute global and growing epidemics that result in therapeutic dead ends. There…
Abstract Background: Cannabidiol (CBD), a safe, non-intoxicating cannabis component, is growing in popularity in Europe and worldwide. However, CBD EU…
Abstract Background: Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is…
Abstract Background: Although cannabis use is common in France, it is still criminalized. Cannabidiol (CBD) products, including CBD-rich cannabis, are…
Abstract Background: Thanks to direct-acting antivirals, hepatitis C virus (HCV) infection can be cured, with similar rates in HCV-infected and…
Abstract Background: Cannabidiol and cannabidiol-based products are proliferating in many countries. This recent and rapid diffusion prompts investigating the reasons…